Resection of acral lentiginous melanoma with sentinel lymph node biopsy and reverse sural flap reconstruction in one stage: a case report
نویسندگان
1 Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Orthopedic Surgery, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Pathology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Department of General and Vascular Surgery, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 Department of Orthopedic Surgery, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
doi
10.22034/ijd.2023.412342.1740چکیده
Acral Lentiginous Melanoma (ALM) is a variant of cutaneous melanoma that occurs on the skin of the palms, soles, and nail units. Despite prompt surgical intervention and advancements in the treatment of these lesions, patient outcomes remain suboptimal. In this report, we present a case of a 69-year-old man with melanoma located on the heel. The lesion was resected, followed by a sentinel lymph node biopsy (SLNB), and the wound was reconstructed using a reverse sural flap. The application of the reverse sural flap technique for wound closure highlights the significance of plastic and reconstructive surgery in optimizing both functional and cosmetic outcomes. By addressing the specific challenges posed by the heel region, this reconstructive approach exemplifies the innovative nature of surgical interventions in complex cases. This case report demonstrates the successful management of ALM on the heel through a combination of SLNB and reverse sural flap reconstruction performed in a single stage. This multidisciplinary approach, guided by accurate staging and innovative surgical techniques, resulted in effective tumor resection, optimal wound closure, and favorable functional outcomes.